Online Consumer Reviews

Drugmakers Blocking Generic Drugs, Jacking Up Drug Prices

Drugmakers of brand name drugs were called out this week by the Trump Administration for hiking prices by double digits. These price hikes have been ongoing since 2012.  These price hikes have cost Medicare and Medicaid nearly $12 billion in 2016. In addition, brand name drug makers have stalled generic drug competition and prevented new generics…

Read More

Drug Price Reduction Decision Put Off By Medicare

Drug price reductions for patients on the Medicare Part D prescription drug program was put off by the CMS (The Centers for Medicare and Medicaid Services) yesterday.     The issue is whether the discounts that pharmacy benefit managers negotiate for drugs should go toward lowering the price that a patient pays at the pharmacy.…

Read More